We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Here are three stocks with buy rank and strong momentum characteristics for investors to consider today, May 22nd:
Gamida Cell Ltd. : This clinical stage biopharmaceutical company has a Zacks Rank #1 (Strong Buy) and witnessed the Zacks Consensus Estimate for its current year earnings increasing 8.1% over the last 60 days.
Cal-Maine Foods, Inc. (CALM - Free Report) : This producer, packager and distributor of shell eggs has a Zacks Rank #1 and witnessed the Zacks Consensus Estimate for its current year earnings increasing more than 100% over the last 60 days.
Atlas Air Worldwide Holdings, Inc. : This provider of outsourced aircraft and aviation operating services has a Zacks Rank #1 and witnessed the Zacks Consensus Estimate for its current year earnings increasing 27.1% over the last 60 days.
Would you like to see the updated picks from our best market-beating strategies? From 2017 through 2019, while the S&P 500 gained and impressive +53.6%, five of our strategies returned +65.8%, +97.1%, +118.0%, +175.7% and even +186.7%.
This outperformance has not just been a recent phenomenon. From 2000 – 2019, while the S&P averaged +6.0% per year, our top strategies averaged up to +54.7% per year.
Image: Bigstock
Top Ranked Momentum Stocks to Buy for May 22nd
Here are three stocks with buy rank and strong momentum characteristics for investors to consider today, May 22nd:
Gamida Cell Ltd. : This clinical stage biopharmaceutical company has a Zacks Rank #1 (Strong Buy) and witnessed the Zacks Consensus Estimate for its current year earnings increasing 8.1% over the last 60 days.
Gamida Cell Ltd. Price and Consensus
Gamida Cell Ltd. price-consensus-chart | Gamida Cell Ltd. Quote
Gamida Cell's shares gained 24.4% over the last one month compared to S&P 500’s rise of 7.7%. The company possesses a Momentum Score of A.
Gamida Cell Ltd. Price
Gamida Cell Ltd. price | Gamida Cell Ltd. Quote
Cal-Maine Foods, Inc. (CALM - Free Report) : This producer, packager and distributor of shell eggs has a Zacks Rank #1 and witnessed the Zacks Consensus Estimate for its current year earnings increasing more than 100% over the last 60 days.
CalMaine Foods, Inc. Price and Consensus
CalMaine Foods, Inc. price-consensus-chart | CalMaine Foods, Inc. Quote
Cal-Maine’s shares gained 9.7% over the last one month. The company possesses a Momentum Score of A.
CalMaine Foods, Inc. Price
CalMaine Foods, Inc. price | CalMaine Foods, Inc. Quote
Atlas Air Worldwide Holdings, Inc. : This provider of outsourced aircraft and aviation operating services has a Zacks Rank #1 and witnessed the Zacks Consensus Estimate for its current year earnings increasing 27.1% over the last 60 days.
Atlas Air Worldwide Holdings Price and Consensus
Atlas Air Worldwide Holdings price-consensus-chart | Atlas Air Worldwide Holdings Quote
Atlas Air's shares gained 43.3% over the last one month. The company possesses a Momentum Score of A.
Atlas Air Worldwide Holdings Price
Atlas Air Worldwide Holdings price | Atlas Air Worldwide Holdings Quote
See the full list of top ranked stocks here
Learn more about the Momentum score and how it is calculated here.
Today's Best Stocks from Zacks
Would you like to see the updated picks from our best market-beating strategies? From 2017 through 2019, while the S&P 500 gained and impressive +53.6%, five of our strategies returned +65.8%, +97.1%, +118.0%, +175.7% and even +186.7%.
This outperformance has not just been a recent phenomenon. From 2000 – 2019, while the S&P averaged +6.0% per year, our top strategies averaged up to +54.7% per year.
See their latest picks free >>